Results 1 to 10 of about 1,327,319 (352)

Global reporting of progress towards elimination of hepatitis B and hepatitis C.

open access: yesThe Lancet Gastroenterology and Hepatology, 2023
BACKGROUND The 69th World Health Assembly endorsed the global health sector strategy on viral hepatitis to eliminate viral hepatitis as a public health threat by 2030.
Fu-Qiang Cui   +20 more
semanticscholar   +1 more source

Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

open access: yesThe Lancet Gastroenterology and Hepatology, 2022
Summary Background Combating viral hepatitis is part of the UN Sustainable Development Goals (SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector Strategy on Viral Hepatitis (WHO-GHSS) and Interim Guidance for Country
Brittney S Lindsey Hannah Helen Mohsen Zeinab Hedayat Amir Sheena Hiebert Han Ippolito Abbasi-Kangevari Abbas   +441 more
semanticscholar   +1 more source

Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment

open access: yesJournal of Patient-Reported Outcomes, 2021
Background In 2019, an estimated 296 million people were living with chronic hepatitis B virus (HBV) globally with approximately 2.4 million living within the United States.
Catherine Freeland   +6 more
doaj   +1 more source

Awareness and treatment of chronic hepatitis B in Malaysia-findings from a community-based screening campaign

open access: yesBMC Gastroenterology, 2022
Introduction In 2016 the World Health Organization (WHO) had adopted a global strategy to eliminate Hepatitis B (HBV) by 2030 through five core interventions.
Zhuo-zhi Lim   +3 more
doaj   +1 more source

Clinical Practice Guidelines on Hepatitis Delta Virus.

open access: yesJournal of Hepatology, 2023
Hepatitis D virus (HDV) is a defective virus requiring the hepatitis B virus (HBV) to complete its life cycle and cause liver damage in humans. HDV is responsible for rare acute and chronic liver diseases and is considered the most aggressive hepatitis ...
M. Brunetto   +10 more
semanticscholar   +1 more source

Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve Elimination [PDF]

open access: yesJournal of Preventive Medicine and Public Health, 2021
Hepatitis C infection is responsible for high morbidity and mortality rates globally as well as for significant indirect costs. The disease burden caused by the hepatitis C virus (HCV) is comparable to the one caused by human immunodeficiency virus or ...
Nathalie Brunner, Philip Bruggmann
doaj   +1 more source

Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023

open access: yesMMWR Recommendations and Reports, 2023
Summary Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality. Although treatment is not considered curative, antiviral treatment, monitoring, and liver cancer surveillance can reduce morbidity and mortality. Effective
E. Conners   +15 more
semanticscholar   +1 more source

The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?

open access: yesArchives of Public Health, 2021
Background Co-infection between hepatitis B virus (HBV) and hepatitis delta virus (HDV) causes the severest chronic hepatitis and is associated with a high risk of cirrhosis and hepatocellular carcinoma (HCC).
Tomoyuki Hayashi   +10 more
doaj   +1 more source

Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study

open access: yesBMC Public Health, 2021
Background An estimated between 257 and 292 million people live with chronic HBV globally. While much is known about the causes, and epidemiology of HBV, little is understood about the quality of life and impact of HBV on those living with the infection.
Catherine Freeland   +8 more
doaj   +1 more source

Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project

open access: yesHarm Reduction Journal, 2022
Background This commentary explores the lessons learned during implementation of a peer-facilitated hepatitis C virus (HCV) testing and treatment access project called the Live Hep C Free (LHCF) project in contributing to micro-elimination efforts.
Julia A. Silano   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy